WO2007081209A1 - Uv-absorbing polymers consisting of gelatin and aminobutadiene - Google Patents
Uv-absorbing polymers consisting of gelatin and aminobutadiene Download PDFInfo
- Publication number
- WO2007081209A1 WO2007081209A1 PCT/NL2007/050010 NL2007050010W WO2007081209A1 WO 2007081209 A1 WO2007081209 A1 WO 2007081209A1 NL 2007050010 W NL2007050010 W NL 2007050010W WO 2007081209 A1 WO2007081209 A1 WO 2007081209A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- carbon atoms
- polypeptide
- polymer
- optionally substituted
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 68
- BUNYBPVXEKRSGY-ONEGZZNKSA-N (1e)-buta-1,3-dien-1-amine Chemical compound N\C=C\C=C BUNYBPVXEKRSGY-ONEGZZNKSA-N 0.000 title claims abstract description 31
- 229920000159 gelatin Polymers 0.000 title claims description 47
- 108010010803 Gelatin Proteins 0.000 title claims description 45
- 235000019322 gelatine Nutrition 0.000 title claims description 45
- 235000011852 gelatine desserts Nutrition 0.000 title claims description 45
- 239000008273 gelatin Substances 0.000 title claims description 31
- 238000000034 method Methods 0.000 claims abstract description 33
- 239000000203 mixture Substances 0.000 claims abstract description 26
- 239000002537 cosmetic Substances 0.000 claims abstract description 20
- 230000008569 process Effects 0.000 claims abstract description 15
- 230000000475 sunscreen effect Effects 0.000 claims abstract description 14
- 239000000516 sunscreening agent Substances 0.000 claims abstract description 14
- 125000003277 amino group Chemical group 0.000 claims abstract description 13
- 238000009472 formulation Methods 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 54
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 52
- 229920001184 polypeptide Polymers 0.000 claims description 51
- 125000004432 carbon atom Chemical group C* 0.000 claims description 30
- 125000000217 alkyl group Chemical group 0.000 claims description 23
- 150000001413 amino acids Chemical class 0.000 claims description 21
- 238000010521 absorption reaction Methods 0.000 claims description 18
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 18
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 125000003107 substituted aryl group Chemical group 0.000 claims description 5
- 108010013296 Sericins Proteins 0.000 claims description 4
- 239000005018 casein Substances 0.000 claims description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 4
- 235000021240 caseins Nutrition 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 4
- 125000004429 atom Chemical group 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 36
- 210000003491 skin Anatomy 0.000 description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 235000001014 amino acid Nutrition 0.000 description 17
- 230000005855 radiation Effects 0.000 description 13
- 238000010168 coupling process Methods 0.000 description 12
- 238000005859 coupling reaction Methods 0.000 description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- BUNYBPVXEKRSGY-UHFFFAOYSA-N buta-1,3-dien-1-amine Chemical class NC=CC=C BUNYBPVXEKRSGY-UHFFFAOYSA-N 0.000 description 10
- 230000008878 coupling Effects 0.000 description 10
- 230000035515 penetration Effects 0.000 description 10
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- -1 hydroxyl radicals Chemical class 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 5
- 125000002947 alkylene group Chemical group 0.000 description 5
- 150000007514 bases Chemical class 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000001627 detrimental effect Effects 0.000 description 5
- 229960002591 hydroxyproline Drugs 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000004473 Threonine Substances 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 4
- 230000008105 immune reaction Effects 0.000 description 4
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004899 c-terminal region Anatomy 0.000 description 3
- 230000001066 destructive effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 238000010188 recombinant method Methods 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 125000002730 succinyl group Chemical group C(CCC(=O)*)(=O)* 0.000 description 3
- BJBUEDPLEOHJGE-UHFFFAOYSA-N (2R,3S)-3-Hydroxy-2-pyrolidinecarboxylic acid Natural products OC1CCNC1C(O)=O BJBUEDPLEOHJGE-UHFFFAOYSA-N 0.000 description 2
- 0 *C(S(*)(=O)=O)=CC=CN(*)* Chemical compound *C(S(*)(=O)=O)=CC=CN(*)* 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- BJBUEDPLEOHJGE-IUYQGCFVSA-N cis-3-hydroxy-D-proline zwitterion Chemical compound O[C@H]1CCN[C@H]1C(O)=O BJBUEDPLEOHJGE-IUYQGCFVSA-N 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 229940113088 dimethylacetamide Drugs 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000033444 hydroxylation Effects 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical class [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- XGKCWNGHLZXLTK-MUWMCQJSSA-N 2-aminoacetic acid;(2s,3r)-2-amino-3-hydroxybutanoic acid Chemical compound NCC(O)=O.C[C@@H](O)[C@H](N)C(O)=O XGKCWNGHLZXLTK-MUWMCQJSSA-N 0.000 description 1
- 125000004398 2-methyl-2-butyl group Chemical group CC(C)(CC)* 0.000 description 1
- 125000004917 3-methyl-2-butyl group Chemical group CC(C(C)*)C 0.000 description 1
- 229940117976 5-hydroxylysine Drugs 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000519995 Stachys sylvatica Species 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 239000004904 UV filter Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 150000007656 barbituric acids Chemical class 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 150000005323 carbonate salts Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- HJSLFCCWAKVHIW-UHFFFAOYSA-N cyclohexane-1,3-dione Chemical class O=C1CCCC(=O)C1 HJSLFCCWAKVHIW-UHFFFAOYSA-N 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical group NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000009851 immunogenic response Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 231100000760 phototoxic Toxicity 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
Definitions
- the present invention is in the field UV-absorbing compounds, in particular useful in sunscreen compositions.
- UV-B radiation with a wavelength of 290 to 315 nm, causes erythema or sunburn. It was not until around 1980 that it was discovered that UV-A radiation, with a wavelength from 315 to 400 nm, causes phototoxic and photochemical reactions. While about 70% UV-B radiation is blocked by the outer skin or stratum corneum, this is not the case for UV-A radiation, which can subsequently penetrate deep into the living dermis. A well known destructive effect of UV-A is oxidative stress.
- Superoxide which is formed by UV-A radiation, can release iron from ferritin, an iron-storage protein located in fibroblasts in the skin (Pourzand et ah, Proc. Natl. Acad. Sci. USA, June 1999, Vol. 96, p. 6751-56).
- the role of iron in the Fenton or Haber Weis reaction resulting in the production of highly destructive hydroxyl radicals and hydrogen peroxide is well known.
- other metal ions like copper-ions have been reported to catalyze the formation of oxygen radicals.
- the role of these destructive products in damaging DNA is well known as for example described by Sestili et al (Free Radical Biology & Medicine [US], July 15 1998, 25, [2] p.196-200).
- WO 2004/006878 discloses merocyanine derivatives for use in cosmetics for protection against UV radiation, but provides no teachings about the benefits or drawbacks of the numerous listed structures.
- organic UV absorbing compounds are their low water solubility. Therefore, they are unsuitable for use in water-based cosmetics like hydrogels. They require the use of organic solvents, which generally exhibit undesired side effects. Lipid soluble UV absorbing compounds, with or without the combination with organic solvents are capable of passing the so-called stratum corneum with the risk of entering the bloodstream. Consequently, there is a need in the art for more hydrophilic UV-absorbing compounds.
- US 4.839.160 discloses a cosmetic formulation for protecting the skin against UV radiation comprising a polymer of benzylidene norbornanone units having C4 - C 12 alkoxy chains.
- this approach does not result in an increase of the hydrophilicity of the UV absorbing compound but into an increase of the hydrophobicity of the UV absorbing compound.
- the increase of the hydrophobicity will result in an increase of the mobility through the lipid elements in the stratum corneum instead of the other way around.
- WO 03/004061 discloses the use of UV-absorbing complexes wherein a flavonoid is coupled to a polypeptide, in particular a polypeptide selected from the group consisting of casein, sericin, soluble collagen and gelatin.
- a polypeptide selected from the group consisting of casein, sericin, soluble collagen and gelatin.
- These UV-absorbing complexes have, however, several disadvantages.
- the coupling method that is disclosed uses formaldehyde as reagent which is a highly toxic material and which causes strong skin irritations.
- cross-linking of the polypeptide occurs as an undesired side-reaction.
- the stability of the complexes is unsatisfactory as has become apparent from stability tests under xenon radiation conditions (see Example 5 of WO 03/004061).
- the complexes absorb visible light and this absorption provides the material a yellow colour which is obviously not desired for sunscreen materials in cosmetic applications.
- EP A 1172399 discloses a method to couple organic compounds to a polymer which has at least one reactive amine group. In this patent application, the use of the synthesized materials for sunscreen applications is not disclosed or suggested.
- US 5.403.944 discloses an organopolysiloxane polymer with UV-absorbing groups.
- JP 3161742 discloses UV absorbers combined with gelatin for use in photographic sensitive material. No cosmetic applications are disclosed or suggested.
- UV filters which provide sufficient direct protection from sunlight by blocking the radiation while not showing any risk of allergic or immunogenic nature and not showing any penetration through the skin and being fully transparent for the visible light radiation.
- WO 2004/075871 discloses a cosmetic composition for protection against UV radiation comprising a cosmetically and dermatologically acceptable carrier and a UV absorbing compound, not being a fiavonoid, which is covalently linked to a polypeptide which is preferably selected from the group consisting of casein, sericin, soluble collagen and gelatin.
- the UV absorbing compound is preferably an amino butadiene of the formula:
- Ri and R 2 which may be the same or different, each represents a hydrogen atom, a linear or branched alkyl group having 1 - 20 carbon atoms, or an aryl group having 6 - 20 carbon atoms, provided that Ri and R 2 do not simultaneously represent hydrogen atoms, optionally Ri and R 2 can combine and form a cyclic amino group; and wherein each of Ri and R 2 may be substituted by one or more carboxy groups (-CO 2 H) or derivatives thereof;
- R3 represents a carboxy group, -COOR5, -COR5 or SO2R5 and R 4 represents a carboxy group, -COOR5 or -COR5 wherein R5 and R 6 , which may be the same or different, each represents a linear or branched alkyl group having 1-20 carbon atoms, or an aryl group having 6 to 20 atoms; optionally R5 and R 6 can combine and form a 1,3- dioxocyclohexane nucleus, a barbituric acid nucleus, or a 2,4-diazo-l-alkoxy-3,5- dioxocyclohexene nucleus.
- the aminobutadienes are coupled to the polypeptides by a method in which crosslinking of the polypeptide does not occur.
- the method involves the conversion of a carboxylic acid containing amino butadiene to an N-succinimide ester by use of a carbodiimide and N-hydroxy succinimide and subsequent coupling of the ester to the polypeptide.
- Non-prepublished WO 2006/009451 discloses UV- absorbing polymers comprising an amino butadiene moiety and a synthetic amine rich polymer. These UV-absorbing polymers can either be prepared according to the method disclosed in WO 2004/075871 or according to a method wherein the amino butadiene is directly coupled to the synthetic amine rich polymer having -NHR* end groups, wherein R* is hydrogen or a linear or branched C 1 - C 6 alkyl group.
- Non-prepublished WO 2006/016806 discloses a particular group of amino butadiene derivatives for use as UV-absorbing compounds.
- the present invention provides an efficacious method for the preparation of UV- absorbing polymers that are based on polymers having at least one amine group
- the present invention provides a method for the preparation of UV-absorbing polymers that are based on polypeptides.
- the present invention provides a process for the preparation of UV- absorbing polymers wherein an amino butadiene derivative according to formula (I) is reacted in the presence of a base with a polymer P having at least one amine group NHR* according to formula (II):
- Ri and R 2 which may be the same or different, each represents a hydrogen atom, an optionally substituted linear or branched alkyl group having 1 - 20 carbon atoms, an optionally substituted aryl group having 6 - 20 carbon atoms, or an optionally substituted alkaryl or arylalkyl group having 7 - 20 carbon atoms, provided that Ri and R 2 do not simultaneously represent hydrogen atoms;
- R 3 represents -COOH, -COOR 5 , -COR 5 , CN or SO 2
- R 5 and R 4 represents -COOH, -COOR5, -COR5, CN or SO 2 R5, wherein R5 and R 6 , which may be the same or different, each represents a linear or branched alkyl group having 1 - 25 carbon atoms, a linear or branched alkyl group having 1 - 25 carbon atoms and one or more carbon-carbon double bonds and/or triple bonds, wherein the alkyl group optionally comprises one or more hetero-atoms selected from the group consisting of O, N, Si and S, an optionally substituted aryl group having 6 to 20 atoms, or an optionally substituted alkaryl or arylalkyl group having 7 - 20 carbon atoms; optionally R5 and R 6 can combine and form a ring structure, said ring structure preferably being a five to seven membered ring structure, which is optionally substituted and which optionally
- R* is hydrogen or a linear or branched Ci - Ce alkyl group; and the polymer P is a polypeptide, provided that the polymer P is not a synthetic amine rich polymer.
- the present invention further relates to the use of the UV-absorbing polymer for the preparation of a cosmetic composition for protection against UV-radiation.
- the aminobutadiene according to the present invention has the general formula (I) disclosed above.
- Ri and R 2 are substituted alkyl groups or substituted aryl groups
- the substituents are preferably selected from the group consisting of carboxy (-CO 2 H), ester (-CO 2 Rs), wherein Rs is a linear or branched Ci - C 5 alkyl group, a C 6 - Ci 2 aryl group, a C 7 - Ci 2 alkaryl group or a C 7 - Ci 2 arylalkyl group, or amide (-CO 2 N(Rs) 2 ), wherein the number of substituents is preferably one to three, more preferably one.
- a preferred class of aminobutadienes is that in which R 3 represents -COOH, -COOR 5 , -COR 5 or SO 2 R 5 and R 4 represents a carboxy group, -COOR 6 , -COR 6 or -SO 2 R 6 , wherein R 1 , R 2 , R5 and R 6 have the meanings indicated above.
- Examples of aminobutadienes according to the general formula (I) are for example disclosed in US 4.195.999. Table 1 lists a number of aminobutadienes according to the present invention which can be coupled directly to polymer P, including their approximate absorption maxima in methanol (or ethanol when not soluble in methanol). The approximated value is based on measurements for different Ri and R 2 groups
- R 1 , R 2 , R 4 and R 5 have the same meaning as in the general formula (I) It was found that the presence of an -SO2R5 group improves the stability of the compounds under UV-light.
- a yet even more preferred class of aminobutadienes according to formula (III) is that wherein R 4 is -COOR5, wherein R 6 has the meaning identified above.
- a yet even more preferred class of aminobutadienes according to the present invention is represented by the general formula (IV), wherein R 1 , R 2 and R 5 are as defined above and wherein R 6 is a linear or branched, preferably linear, alkyl group having 10 - 20 carbon atoms, even more preferably 12 - 20 carbon atoms en most preferably 12 - 18 carbon atoms:
- At least one of Ri and R 2 is a group of the formula R 7 -C(O)-, wherein R 7 is a hydrogen atom or an optionally substituted linear or branched alkyl group having 1 to 20 carbon atoms.
- one of Ri and R 2 is a group of the formula R 7 -C(O)- whereas the other is an optionally substituted phenyl group of 6 to 20 carbon atoms.
- a most preferred group of the aminobutadiene according to the formulas (I) and (III) is:
- R 6 has the same meaning as in general formula (I).
- UVl the compound according to formula (V) wherein R 6 is ethyl
- R 7 can be a hydrogen or a optionally substituted linear or branched alkyl group having 1 to 20 carbon atoms.
- Another example of the aminobutadiene according to the formulas (I) and (III) is a compound according to formula (V), wherein R 6 is n-Cie ⁇ f ⁇ .
- R 7 is a substituted alkyl group
- the substituents are preferably selected from the group consisting of carboxy (-CO 2 H), ester (-CO 2 Rs), wherein R 8 is a linear or branched Ci - C 5 alkyl group, a C 6 - Ci 2 aryl group, a C 7 - Ci 2 alkaryl group or a C 7 - C 12 arylalkyl group, or amide (-CO 2 N(Rs) 2 )
- the number of substituents is preferably one to three, more preferably one.
- R 7 has less than or equal to 12 carbon atoms. More preferably, R 7 has 1 to 8 carbon atoms. Even more preferably, R 7 has 1, 2, 3, 4 or 5 carbon atoms, because the effect on the absorption maximum is very small when the alkyl group contains more than 6 carbon atoms.
- Examples of most preferred alkyl groups for R 7 are methyl, ethyl, 1 -propyl, 2-propyl, n-butyl, s-butyl, t-butyl, 2-methyl-l -propyl, 2-methyl-2- propyl, 1-pentyl, 2-pentyl, 3-pentyl, 2-methyl-l -butyl, 2-methyl-2-butyl, 3-methyl-2- butyl, 3 -methyl- 1 -butyl and 2,2-dimethyl-l -propyl.
- the polymer P is a polypeptide comprising at least one amine group -NHR* as is disclosed above, provided that the polymer P is not a synthetic amine rich polymer as disclosed in non-prepublished WO 2006/009451 (priority date 23 July 2004).
- the polymer P may not only be of natural origin, but also of synthetic origin, e.g. as can be obtained by recombinant techniques, or a synthetic or natural polymer that is further modified by chemical methods, e.g. grafting techniques.
- the molecular weight of polymer P is preferably less than 300 kD, more preferably less than 100 kD, even more preferably less and 50 kD.
- the molecular weight is preferably at least 1 kD.
- a more preferred range is a molecular weight of polymer P of 1 to 30, even more preferred is a range of 1 to 20 kD.
- a molecular weight range of 1.5 to 10 kD is even more preferred.
- the molecular weight is less than 6 kD, comprising molecular weights of 2.0, 3.0, 4.0 and 5.0 kD.
- a polypeptide is to be understood to comprise any molecule or polymer having at least 15 amino acids linked by peptide bonds, including natural proteins, denatured proteins, synthetic and recombinant proteins and peptides, glycoproteins, proteoglycans, lipoproteins and other molecules which may contain other groups, including bio-oligomer or polypeptide groups as a side chain or in the chain.
- the maximum length is usually 3000 amino acids. Consequently, according to the invention, the polypeptide comprises 10 - 2000 amino acids. Preferably, the polypeptide comprises less than 500 amino acids. Polypeptides comprising 15 to 100 amino acids are more preferred. Even more preferred are polypeptides comprising less 60 amino acids.
- the polypeptide is a collagen-like or gelatin-like polypeptide comprising at least one stretch of five or more consecutive repeats of Gly-Xaa-Yaa triplets, wherein it is preferred that in the collagen-like or gelatin-like polypeptide at least 20% of the amino acids are present in the form of consecutive Gly-Xaa-Yaa triplets. Preferably at least 50% of the aminoacids are present in the form of consecutive Gly-Xaa-Yaa triplets.
- a collagen- or gelatin-like polypeptide may have 100% of its aminoacids present in the form of consecutive Gly-Xaa-Yaa triplets.
- Collagen-like or gelatin-like polypeptides according to the invention are preferably identical or essentially similar to natural human collagen amino acid sequences and non-human sequences (such as rat, rabbit, mouse etc.). Also sequences can be designed that do not occur naturally but which are obtained by recombinant techniques.
- the term "essentially similar" means that two peptide sequences, when optimally aligned, such as by the programs GAP or BESTFIT using default parameters, share at least 80 percent sequence identity, preferably at least 90 percent sequence identity, more preferably at least 95 percent sequence identity or more (e.g., 99 or 100 percent sequence identity).
- threonine residues, serine residues, the residues adjacent to the N-terminal or the C-terminal of threonine and 50% of the residues adjacent to the C-terminal side of the serine residues must be disregarded.
- a natural sequence having a threonine is 100% identical to the same sequence wherein the threonine has been replaced by any other amino acid and the same is true for a sequence having an amino acid-threonine tandem wherein said amino acid is not a glycine compared with a natural sequence having glycine-threonine tandem (assuming the N-terminal is to the left and C-terminal to the right).
- a collagen-like or gelatin-like polypeptide in its primary amino acid sequence basically consists of repeats of Gly-Xaa-Yaa triplets, thus approximately one third of the total number of amino acids is a glycine.
- characteristic for the collagen-like or gelatin-like polypeptide is the unusual high content of proline residues. Even more characteristic is that in the collagen-like or gelatin-like polypeptide a number of the proline residues are hydroxylated. The most prominent site of hydroxylation is the 4-position resulting in the presence in the collagen-like or gelatin-like polypeptide of the unusual amino acid 4-hydroxyproline. In a triplet 4-hydroxyproline is always found in the Yaa position. Very few proline residues are hydroxylated at the 3 position. In contrast with 4- hydroxyproline, 3-hydroxyproline is always found at the carboxy side of a glycine residue, thus in the Xaa position in a triplet. Different enzymes are responsible for the formation of 3- or 4-hydroxyproline.
- Another amino acid present in the collagen-like or gelatin-like polypeptide is 5-hydroxylysine. Lysine residues modified in this way are always found in the Yaa position in a triplet.
- the polypeptide is selected from the group consisting of casein, sericin, soluble collagen, gelatin and derivatives thereof.
- the polypeptide is gelatin or a derivative thereof because of the low antigenicity and immunogenicity, the latter comprising most preferably between 30 and 300 amino acids. If there is a desire to avoid immune reactions even further, for example in case of individuals suffering from (auto-)immune diseases, gelatins incapable of helix-formation can be advantageously used. This can be achieved by chemically modifying gelatins to impair helix formation or, preferably, by using gelatins produced by recombinant techniques as for example disclosed in EP A 1.063.665.
- Such recombinant gelatins may lack prolines in the peptide backbone or hydroxylation to hydroxy-proline can be reduced or prevented or avoided. Such recombinant gelatins are preferred over modified gelatins because they less likely to elicit immune reactions.
- the term "gelatin or a derivative thereof encompasses materials such as fish gelatin in case the gelling function of the polypeptide is not desired and a larger polypeptide is wished, hydro lysed gelatin, chemically modified gelatin.
- hydro lysed gelatin has a molecular weight of less than 50 kD and more than 1.5 kD, which is adequate to prevent the skin penetration of the UV absorbing polypeptide complex and showing rather limited or even fully absent gelling properties. Most preferably, hydro lysed gelatin has a molecular weight between 3 kD and 30 kD.
- Gelatins that can be used as the polypeptide are preferably acid or lime treated skin or bone gelatins from mammals or cold-blooded animals. Such gelatins are common in the prior art and are well described in literature.
- Chemically modified gelatins are also known in the art. Examples include trimellitated, succinylated, acylated, alkylated, phthalated gelatin. Chemically modified gelatins can advantageously be used as long as they do not elicit detrimental reactions like immune reactions when applied to the skin. Succinylated gelatins for example are applied as blood plasma expanders, and are medically and immunologically acceptable gelatin. Alkylated gelatins, cf. for example. DE 19721238 for alkylene succinated gelatin, can be used to alter the interaction of the polypeptide with the skin and hence influence the water fastness of the UV-absorbing polymer.
- alkyl groups such as for example alkylene succinyl groups
- alkylene succinyl groups may additionally be coupled to the carrier in the UV-absorbing compound.
- Alternatives for alkylene succinyl groups are readily known to the skilled person or can easily be identified in terms of having an improved water fastness.
- the invention relates to UV-absorbing polymers as defined above wherein the polymer P further comprises alkyl groups, preferably alkylene succinyl groups, to improve water fastness, wherein the alkyl groups and the alkylene groups have 4 to 25 carbon atoms.
- Modified gelatins in which the amount of free amine-groups has been increased can be used to increase the load of the amino butadienes according to formula (I) on the gelatin.
- EP A 487.686 discloses a method to convert carboxy groups into amines.
- spacers can be used to increase the amount of free reactive groups in a polypeptide.
- a spacer is a molecule which can be covalently linked to reactive groups of the polypeptide, like carboxy groups or amine groups, said spacer molecule comprising at least two reactive groups like amine groups or carboxy groups.
- suitable spacers are amino acids, e.g. lysine, glutamic acid and aspartic acid. Coupling of the aminobutadiene to the polymer P
- the aminobutadiene according to formula (I) is coupled directly to polymer P by mixing the aminobutadiene with the polymer P.
- the aminobutadiene is coupled to polymer P in an amount of at least about 7.6 mmol per 100 gram polymer P, preferably in an amount of at least about 10 mmol per 100 gram polymer P, more preferably at least about 20 mmol per 100 gram polymer P, even more preferably at least about 40 mmol per 100 gram polymer P and most preferably at least about 100 mmol per 100 gram polymer P.
- the amount of aminobutadienes used can also be expressed as a percentage of amine groups in polymer P which is bonded to an amino butadiene.
- 100% of the amine groups is coupled to an aminobutadiene.
- good results can already be obtained when more than 50% of the amine groups is linked to an aminobutadiene.
- the coupled amounts necessary to reach the preferred UV-absorption may obviously vary between different aminobutadiene structures since said aminobutadiene structures can be expected to have varying extinction coefficients.
- High molecular weight of polypeptides i.e. over 100 kD, are less preferred. Such large molecules may give problems as to insufficient penetration in cosmetic applications.
- the molecular weight of conventional natural or modified polypeptides, in particular gelatins can be regulated by for example hydrolysis or by enzymatic breakdown of the polypeptide.
- the desired average molecular weight can be regulated satisfactorily, although the molecular weight distribution can be problematic.
- larger fragments can be removed by known techniques such as ultra filtration, dialysis, noodle washing and the like.
- Recombinant produced gelatins have the additional advantage that the molecular weight and the molecular weight distribution can be regulated precisely.
- Another method to regulate skin penetration is to adjust the hydrophobicity of the polypeptide by chemical modification of the polypeptide, covalently linking hydrophilic or hydrophobic groups to the polypeptide.
- the direct coupling process can be performed in various solvents.
- Preferred solvents are those in which gelatin and the aminobutadiene dissolve completely.
- Preferred solvents are those selected from the group consisting of dimethyl formamide (DMF), dimethyl acetamide (DMAC), dimethylsulfoxide (DMSO), N-methyl pyrollidone (NMP), 1,2-ethanediol, tetrahydrofuran (THF), water and mixtures thereof.
- the coupling reaction can be carried out in any suitable reaction vessel at a temperature between -20 0 C and 150 0 C, depending on the solvent(s) used.
- the aminobutadiene may be instable.
- the temperature is between 0 0 C and 100 0 C. More preferred are temperatures between 10 0 C and 80 0 C. Other suitable temperatures are from 20 0 C and 30 0 C. At higher gelatin concentrations temperatures of between than 35°C and 50 0 C may be preferred.
- a base or a basic compound is present during direct coupling.
- Use of such basic compounds may increase the coupling yield with at least 30% - 50%.
- Suitable organic basic compounds comprise tertiary amines such as for example triethylamine and diisopropylethylamine.
- Suitable inorganic basic compounds are for example carbonate salts and hydroxides.
- the preferred amount of basic compound added is between 0.2 and 3 mol equivalents of the aminobutadiene. Preferably, between 0.5 and 2 mol equivalents are added, and most preferably from 0.7 to 1.0 mol equivalents.
- the amount of organic base necessary to reach a specific yield can be up 1.5 times higher compared to an inorganic base.
- the method according to the present invention has an advantage over the method disclosed in WO 2004/075871 since no activation steps or other pre- coupling steps are necessary to couple the polymer P to the aminobutadiene.
- the a UV-absorbing polymer according to the invention that is prepared by coupling an aminobutadiene of formula (I) to the polymer P according to formula (II) has a UV-absorption of at least 5.6 a.u./g.L at 375 nm. This minimum UV-absorption is required to avoid any detrimental effects on the stability and viscosity of the sunscreen formulation.
- a lower absorption than 5.6 a.u./g.L at 375 nm requires a higher amount of the UV-absorbing polymer in the sunscreen composition giving rise to formulation problems such as stability and viscosity problems.
- the UV-absorbing polymer of this invention has a UV-absorption of at least 20 a.u./g.L, more preferably of al least 25 a.u./g.L, even more preferably of at least 30 a.u./g.L and most preferably of at least 40 a.u./g.L.
- the present invention is also directed to the use of the UV-absorbing polymers according to the invention to protect the human skin or hair from the detrimental effects of exposure to sunlight.
- the present invention is especially directed to sunscreen compositions comprising stable UV-absorbing polymers that cannot penetrate through the skin into the bloodstream. Preventing the UV absorbing compound from entering the bloodstream reduces the risk of immune reactions or other detrimental effects.
- the UV-absorbing polymer absorbs less than 10% of its total absorption above 400 nm. This means that the UV-absorbing polymer is substantially transparent for visible light. In a preferred embodiment, the UV-absorbing polymer has 75% or more of its total absorption in the UV-A region between 315 and 400 nm.
- the invention relates to a UV-absorbing polymer as defined above wherein less than 10% of the total absorption between 250 and 600 nm of said UV- absorbing compound is above 400 nm. Also the invention relates to a UV-absorbing polymer as defined above wherein at least 75% of the total absorption between 250 and 600 nm of said UV-absorbing compound is between 315 and 400 nm.
- the depth of penetration in the skin can be advantageously regulated by controlling the molecular weight of the UV-absorbing polymer which prevents it from entering the bloodstream.
- no methods are known to control the skin penetration, but allow skin penetration freely. In the present invention even shallow penetration of the skin is prevented.
- the UV-absorbing compound can be advantageously used for the preparation of cosmetic or sunscreen compositions to protect the skin or hair from UV radiation.
- Various forms of cosmetic compositions for skin protection comprising UV- absorbing compounds are available in the market as lotions, emulsions, creams, milks, gels and the like. These may contain oil and/or alcohol. Also aerosols or sticks are known to be used. All such forms of cosmetic compositions may function as a medium to apply the polypeptide.
- suitable cosmetically and dermatologically carriers that can be used in the sunscreen composition of the invention, in particular in combination which polypeptide to which aminobutadiene is linked.
- the sunscreen comprising can contain a second, conventional, UV-absorbing compound. This can be a UV-A, UV-B or broadband UV absorbing compound as described in for example EP A 1.055.412. Other additives as applied in the art may also be used.
- the cosmetic compositions of the present invention can contain in addition to the
- UV-absorbing compound various adjuvants conventionally present in cosmetic compositions of this type for example hydrating agents, emollients or thickening agents, surfactants, preservatives, perfumes, dyes, etcetera.
- the invention further relates to a sunscreen composition comprising less than 18 wt%, preferably less than 13 wt%, more preferably less than 10 wt% of the UV- polymer compound according to the present invention.
- the specific absorption is determined by UV-spectroscopy at 370 nm and is defined as the absorption of a 1% (10 g/L) solution at a path length of 1 cm.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to a process for the preparation of UV-absorbing polymers wherein an aminobutadiene derivative according to formula (I) is reacted with a polymer P having at least one amine group -NHR* according to formula (II).The UV-absorbing polymers are suitable for use in cosmetic formulations, in particular sunscreen formulations.
Description
UV-ABSORBING POLYMERS CONSISTING OF GELATIN AND AMINOBUTADIENΞ
FIELD OF THE INVENTION
The present invention is in the field UV-absorbing compounds, in particular useful in sunscreen compositions.
BACKGROUND OF THE INVENTION
The detrimental effects of exposing the skin to UV light are manifold and are well documented in the prior art. It has been long recognized that UV-B radiation, with a wavelength of 290 to 315 nm, causes erythema or sunburn. It was not until around 1980 that it was discovered that UV-A radiation, with a wavelength from 315 to 400 nm, causes phototoxic and photochemical reactions. While about 70% UV-B radiation is blocked by the outer skin or stratum corneum, this is not the case for UV-A radiation, which can subsequently penetrate deep into the living dermis. A well known destructive effect of UV-A is oxidative stress. Superoxide, which is formed by UV-A radiation, can release iron from ferritin, an iron-storage protein located in fibroblasts in the skin (Pourzand et ah, Proc. Natl. Acad. Sci. USA, June 1999, Vol. 96, p. 6751-56). The role of iron in the Fenton or Haber Weis reaction resulting in the production of highly destructive hydroxyl radicals and hydrogen peroxide is well known. Also other metal ions like copper-ions have been reported to catalyze the formation of oxygen radicals. The role of these destructive products in damaging DNA is well known as for example described by Sestili et al (Free Radical Biology & Medicine [US], July 15 1998, 25, [2] p.196-200).
The normal biochemical protection by enzymes like superoxide dismutase is not sufficient to effectively stop the reaction induced by UV-A radiation. Hence the necessity to protect the skin from these harmful effects is still mandatory. Other oxidative stress phenomena are damaging of collagen resulting for example in accelerated skin aging and white spots, or damaging of cell walls by lipid peroxidation. The use of organic UV absorbers for sunscreen applications is widely known and reference is for example made to US 5.945.091, US 6.238.648, US 4.950.467 and EP A 895.776.
Recent interest focuses in particular on 1 -amino- 1,3 -butadienes and derivatives (also known as merocyanine derivatives) thereof. Such compounds are also known in the art, cf. for example US 2.617.827, US 4.045.229, US 4.195.999 and US 4.309.500.
WO 2004/006878 discloses merocyanine derivatives for use in cosmetics for protection against UV radiation, but provides no teachings about the benefits or drawbacks of the numerous listed structures.
However, a disadvantage of many organic UV absorbing compounds is their low water solubility. Therefore, they are unsuitable for use in water-based cosmetics like hydrogels. They require the use of organic solvents, which generally exhibit undesired side effects. Lipid soluble UV absorbing compounds, with or without the combination with organic solvents are capable of passing the so-called stratum corneum with the risk of entering the bloodstream. Consequently, there is a need in the art for more hydrophilic UV-absorbing compounds.
To enhance the hydrophilicity, it is proposed in the art to couple UV absorbing compounds to certain polymeric systems. For example, US 4.839.160 discloses a cosmetic formulation for protecting the skin against UV radiation comprising a polymer of benzylidene norbornanone units having C4 - C12 alkoxy chains. However, this approach does not result in an increase of the hydrophilicity of the UV absorbing compound but into an increase of the hydrophobicity of the UV absorbing compound. In addition, although the effect on the penetration through the skin is disclosed, the increase of the hydrophobicity will result in an increase of the mobility through the lipid elements in the stratum corneum instead of the other way around.
The coupling of UV-A and UV-B absorbing compounds to a polyacrylic acid through an oxygen or nitrogen atom is disclosed in WO 01/08647, resulting in a molecular complex designed specifically for the uptake of apolar compounds to adapt the refractive index into a desired direction. However, mixing with oily compounds has the risk of skin penetration in case of smaller molecular weight complexes that could result in undesired immunogenic reactions.
WO 03/004061 discloses the use of UV-absorbing complexes wherein a flavonoid is coupled to a polypeptide, in particular a polypeptide selected from the group consisting of casein, sericin, soluble collagen and gelatin. These UV-absorbing complexes have, however, several disadvantages. The coupling method that is disclosed uses formaldehyde as reagent which is a highly toxic material and which
causes strong skin irritations. Furthermore, cross-linking of the polypeptide occurs as an undesired side-reaction. Also, the stability of the complexes is unsatisfactory as has become apparent from stability tests under xenon radiation conditions (see Example 5 of WO 03/004061). Finally, the complexes absorb visible light and this absorption provides the material a yellow colour which is obviously not desired for sunscreen materials in cosmetic applications.
EP A 1172399 discloses a method to couple organic compounds to a polymer which has at least one reactive amine group. In this patent application, the use of the synthesized materials for sunscreen applications is not disclosed or suggested. US 5.403.944 discloses an organopolysiloxane polymer with UV-absorbing groups.
JP 3161742 discloses UV absorbers combined with gelatin for use in photographic sensitive material. No cosmetic applications are disclosed or suggested.
In spite of these attempts, there remains a need for UV filters which provide sufficient direct protection from sunlight by blocking the radiation while not showing any risk of allergic or immunogenic nature and not showing any penetration through the skin and being fully transparent for the visible light radiation.
WO 2004/075871 discloses a cosmetic composition for protection against UV radiation comprising a cosmetically and dermatologically acceptable carrier and a UV absorbing compound, not being a fiavonoid, which is covalently linked to a polypeptide which is preferably selected from the group consisting of casein, sericin, soluble collagen and gelatin. The UV absorbing compound is preferably an amino butadiene of the formula:
wherein Ri and R2, which may be the same or different, each represents a hydrogen atom, a linear or branched alkyl group having 1 - 20 carbon atoms, or an aryl group having 6 - 20 carbon atoms, provided that Ri and R2 do not simultaneously represent hydrogen atoms, optionally Ri and R2 can combine and form a cyclic amino group; and
wherein each of Ri and R2 may be substituted by one or more carboxy groups (-CO2H) or derivatives thereof;
R3 represents a carboxy group, -COOR5, -COR5 or SO2R5 and R4 represents a carboxy group, -COOR5 or -COR5 wherein R5 and R6, which may be the same or different, each represents a linear or branched alkyl group having 1-20 carbon atoms, or an aryl group having 6 to 20 atoms; optionally R5 and R6 can combine and form a 1,3- dioxocyclohexane nucleus, a barbituric acid nucleus, or a 2,4-diazo-l-alkoxy-3,5- dioxocyclohexene nucleus. The aminobutadienes are coupled to the polypeptides by a method in which crosslinking of the polypeptide does not occur. In particular, the method involves the conversion of a carboxylic acid containing amino butadiene to an N-succinimide ester by use of a carbodiimide and N-hydroxy succinimide and subsequent coupling of the ester to the polypeptide.
Non-prepublished WO 2006/009451 (priority date 23 July 2004) discloses UV- absorbing polymers comprising an amino butadiene moiety and a synthetic amine rich polymer. These UV-absorbing polymers can either be prepared according to the method disclosed in WO 2004/075871 or according to a method wherein the amino butadiene is directly coupled to the synthetic amine rich polymer having -NHR* end groups, wherein R* is hydrogen or a linear or branched C1 - C6 alkyl group.
Non-prepublished WO 2006/016806 (priority date 11 August 2004) discloses a particular group of amino butadiene derivatives for use as UV-absorbing compounds.
SUMMARY OF THE INVENTION
The present invention provides an efficacious method for the preparation of UV- absorbing polymers that are based on polymers having at least one amine group
-NHR*, wherein R* is hydrogen or a linear or branched Ci - C6 alkyl group. In particular, the present invention provides a method for the preparation of UV-absorbing polymers that are based on polypeptides.
Accordingly, the present invention provides a process for the preparation of UV- absorbing polymers wherein an amino butadiene derivative according to formula (I) is
reacted in the presence of a base with a polymer P having at least one amine group NHR* according to formula (II):
(I) (H)
wherein:
Ri and R2, which may be the same or different, each represents a hydrogen atom, an optionally substituted linear or branched alkyl group having 1 - 20 carbon atoms, an optionally substituted aryl group having 6 - 20 carbon atoms, or an optionally substituted alkaryl or arylalkyl group having 7 - 20 carbon atoms, provided that Ri and R2 do not simultaneously represent hydrogen atoms;
R3 represents -COOH, -COOR5, -COR5, CN or SO2R5 and R4 represents -COOH, -COOR5, -COR5, CN or SO2R5, wherein R5 and R6, which may be the same or different, each represents a linear or branched alkyl group having 1 - 25 carbon atoms, a linear or branched alkyl group having 1 - 25 carbon atoms and one or more carbon-carbon double bonds and/or triple bonds, wherein the alkyl group optionally comprises one or more hetero-atoms selected from the group consisting of O, N, Si and S, an optionally substituted aryl group having 6 to 20 atoms, or an optionally substituted alkaryl or arylalkyl group having 7 - 20 carbon atoms; optionally R5 and R6 can combine and form a ring structure, said ring structure preferably being a five to seven membered ring structure, which is optionally substituted and which optionally comprises N, O and/or carbonyl groups;
R* is hydrogen or a linear or branched Ci - Ce alkyl group; and the polymer P is a polypeptide, provided that the polymer P is not a synthetic amine rich polymer.
The present invention further relates to the use of the UV-absorbing polymer for the preparation of a cosmetic composition for protection against UV-radiation.
DETAILED DESCRIPTION OF THE INVENTION
The aminobutadiene according to formula (I)
The aminobutadiene according to the present invention has the general formula (I) disclosed above.
If Ri and R2 are substituted alkyl groups or substituted aryl groups, the substituents are preferably selected from the group consisting of carboxy (-CO2H), ester (-CO2Rs), wherein Rs is a linear or branched Ci - C5 alkyl group, a C6 - Ci2 aryl group, a C7 - Ci2 alkaryl group or a C7 - Ci2 arylalkyl group, or amide (-CO2N(Rs)2), wherein the number of substituents is preferably one to three, more preferably one.
A preferred class of aminobutadienes is that in which R3 represents -COOH, -COOR5, -COR5 or SO2R5 and R4 represents a carboxy group, -COOR6, -COR6 or -SO2R6, wherein R1, R2, R5 and R6 have the meanings indicated above. Examples of aminobutadienes according to the general formula (I) are for example disclosed in US 4.195.999. Table 1 lists a number of aminobutadienes according to the present invention which can be coupled directly to polymer P, including their approximate absorption maxima in methanol (or ethanol when not soluble in methanol). The approximated value is based on measurements for different Ri and R2 groups
Table 1
Of the aminobutadienes according to the formula (I), an even more preferred class is that represented by the following formula (III):
(III)
wherein R1, R2, R4 and R5 have the same meaning as in the general formula (I) It was found that the presence of an -SO2R5 group improves the stability of the compounds under UV-light.
A yet even more preferred class of aminobutadienes according to formula (III) is that wherein R4 is -COOR5, wherein R6 has the meaning identified above.
A yet even more preferred class of aminobutadienes according to the present invention is represented by the general formula (IV), wherein R1, R2 and R5 are as defined above and wherein R6 is a linear or branched, preferably linear, alkyl group
having 10 - 20 carbon atoms, even more preferably 12 - 20 carbon atoms en most preferably 12 - 18 carbon atoms:
(IV)
Preferably, at least one of Ri and R2 is a group of the formula R7-C(O)-, wherein R7 is a hydrogen atom or an optionally substituted linear or branched alkyl group having 1 to 20 carbon atoms.
More preferably, one of Ri and R2 is a group of the formula R7-C(O)- whereas the other is an optionally substituted phenyl group of 6 to 20 carbon atoms.
A most preferred group of the aminobutadiene according to the formulas (I) and (III) is:
wherein R6 has the same meaning as in general formula (I). Hereinafter the compound according to formula (V) wherein R6 is ethyl is referred to as UVl. R7 can be a hydrogen or a optionally substituted linear or branched alkyl group having 1 to 20 carbon atoms. Another example of the aminobutadiene according to the formulas (I) and (III) is a compound according to formula (V), wherein R6 is n-Cieϊfø.
IfR7 is a substituted alkyl group, the substituents are preferably selected from the group consisting of carboxy (-CO2H), ester (-CO2Rs), wherein R8 is a linear or branched Ci - C5 alkyl group, a C6 - Ci2 aryl group, a C7 - Ci2 alkaryl group or a C7 -
C12 arylalkyl group, or amide (-CO2N(Rs)2) The number of substituents is preferably one to three, more preferably one.
Preferably, R7 has less than or equal to 12 carbon atoms. More preferably, R7 has 1 to 8 carbon atoms. Even more preferably, R7 has 1, 2, 3, 4 or 5 carbon atoms, because the effect on the absorption maximum is very small when the alkyl group contains more than 6 carbon atoms. Examples of most preferred alkyl groups for R7 are methyl, ethyl, 1 -propyl, 2-propyl, n-butyl, s-butyl, t-butyl, 2-methyl-l -propyl, 2-methyl-2- propyl, 1-pentyl, 2-pentyl, 3-pentyl, 2-methyl-l -butyl, 2-methyl-2-butyl, 3-methyl-2- butyl, 3 -methyl- 1 -butyl and 2,2-dimethyl-l -propyl.
The polymer P
According to the present invention, the polymer P is a polypeptide comprising at least one amine group -NHR* as is disclosed above, provided that the polymer P is not a synthetic amine rich polymer as disclosed in non-prepublished WO 2006/009451 (priority date 23 July 2004). Within the context of this invention, it should be understood that the polymer P may not only be of natural origin, but also of synthetic origin, e.g. as can be obtained by recombinant techniques, or a synthetic or natural polymer that is further modified by chemical methods, e.g. grafting techniques. The molecular weight of polymer P is preferably less than 300 kD, more preferably less than 100 kD, even more preferably less and 50 kD. The molecular weight is preferably at least 1 kD. A more preferred range is a molecular weight of polymer P of 1 to 30, even more preferred is a range of 1 to 20 kD. A molecular weight range of 1.5 to 10 kD is even more preferred. Most preferably, the molecular weight is less than 6 kD, comprising molecular weights of 2.0, 3.0, 4.0 and 5.0 kD.
Within the context of this invention, a polypeptide is to be understood to comprise any molecule or polymer having at least 15 amino acids linked by peptide bonds, including natural proteins, denatured proteins, synthetic and recombinant proteins and peptides, glycoproteins, proteoglycans, lipoproteins and other molecules which may contain other groups, including bio-oligomer or polypeptide groups as a side chain or in the chain. The maximum length is usually 3000 amino acids. Consequently, according to the invention, the polypeptide comprises 10 - 2000 amino acids. Preferably, the polypeptide comprises less than 500 amino acids. Polypeptides
comprising 15 to 100 amino acids are more preferred. Even more preferred are polypeptides comprising less 60 amino acids.
According to a preferred embodiment of the present invention, the polypeptide is a collagen-like or gelatin-like polypeptide comprising at least one stretch of five or more consecutive repeats of Gly-Xaa-Yaa triplets, wherein it is preferred that in the collagen-like or gelatin-like polypeptide at least 20% of the amino acids are present in the form of consecutive Gly-Xaa-Yaa triplets. Preferably at least 50% of the aminoacids are present in the form of consecutive Gly-Xaa-Yaa triplets. A collagen- or gelatin-like polypeptide may have 100% of its aminoacids present in the form of consecutive Gly-Xaa-Yaa triplets.
Collagen-like or gelatin-like polypeptides according to the invention are preferably identical or essentially similar to natural human collagen amino acid sequences and non-human sequences (such as rat, rabbit, mouse etc.). Also sequences can be designed that do not occur naturally but which are obtained by recombinant techniques. The term "essentially similar" means that two peptide sequences, when optimally aligned, such as by the programs GAP or BESTFIT using default parameters, share at least 80 percent sequence identity, preferably at least 90 percent sequence identity, more preferably at least 95 percent sequence identity or more (e.g., 99 or 100 percent sequence identity). When calculating the percentage of sequence identity in the context of this invention the threonine residues, serine residues, the residues adjacent to the N-terminal or the C-terminal of threonine and 50% of the residues adjacent to the C-terminal side of the serine residues must be disregarded. Thus for example a natural sequence having a threonine is 100% identical to the same sequence wherein the threonine has been replaced by any other amino acid and the same is true for a sequence having an amino acid-threonine tandem wherein said amino acid is not a glycine compared with a natural sequence having glycine-threonine tandem (assuming the N-terminal is to the left and C-terminal to the right). GAP uses the Needleman and Wunsch global alignment algorithm to align two sequences over their entire length, maximizing the number of matches and minimizes the number of gaps. Generally, the GAP default parameters are used, with a gap creation penalty = 50 (nucleotides) / 8 (proteins) and gap extension penalty = 3 (nucleotides) / 2 (proteins).
A collagen-like or gelatin-like polypeptide in its primary amino acid sequence basically consists of repeats of Gly-Xaa-Yaa triplets, thus approximately one third of the total number of amino acids is a glycine.
Furthermore, characteristic for the collagen-like or gelatin-like polypeptide is the unusual high content of proline residues. Even more characteristic is that in the collagen-like or gelatin-like polypeptide a number of the proline residues are hydroxylated. The most prominent site of hydroxylation is the 4-position resulting in the presence in the collagen-like or gelatin-like polypeptide of the unusual amino acid 4-hydroxyproline. In a triplet 4-hydroxyproline is always found in the Yaa position. Very few proline residues are hydroxylated at the 3 position. In contrast with 4- hydroxyproline, 3-hydroxyproline is always found at the carboxy side of a glycine residue, thus in the Xaa position in a triplet. Different enzymes are responsible for the formation of 3- or 4-hydroxyproline.
Furthermore, another amino acid present in the collagen-like or gelatin-like polypeptide is 5-hydroxylysine. Lysine residues modified in this way are always found in the Yaa position in a triplet.
According to another preferred embodiment of the present invention, the polypeptide is selected from the group consisting of casein, sericin, soluble collagen, gelatin and derivatives thereof. Most preferably, the polypeptide is gelatin or a derivative thereof because of the low antigenicity and immunogenicity, the latter comprising most preferably between 30 and 300 amino acids. If there is a desire to avoid immune reactions even further, for example in case of individuals suffering from (auto-)immune diseases, gelatins incapable of helix-formation can be advantageously used. This can be achieved by chemically modifying gelatins to impair helix formation or, preferably, by using gelatins produced by recombinant techniques as for example disclosed in EP A 1.063.665. Such recombinant gelatins may lack prolines in the peptide backbone or hydroxylation to hydroxy-proline can be reduced or prevented or avoided. Such recombinant gelatins are preferred over modified gelatins because they less likely to elicit immune reactions. The term "gelatin or a derivative thereof encompasses materials such as fish gelatin in case the gelling function of the polypeptide is not desired and a larger polypeptide is wished, hydro lysed gelatin, chemically modified gelatin.
Preferably, hydro lysed gelatin has a molecular weight of less than 50 kD and more than 1.5 kD, which is adequate to prevent the skin penetration of the UV absorbing polypeptide complex and showing rather limited or even fully absent gelling properties. Most preferably, hydro lysed gelatin has a molecular weight between 3 kD and 30 kD.
Gelatins that can be used as the polypeptide are preferably acid or lime treated skin or bone gelatins from mammals or cold-blooded animals. Such gelatins are common in the prior art and are well described in literature.
Chemically modified gelatins are also known in the art. Examples include trimellitated, succinylated, acylated, alkylated, phthalated gelatin. Chemically modified gelatins can advantageously be used as long as they do not elicit detrimental reactions like immune reactions when applied to the skin. Succinylated gelatins for example are applied as blood plasma expanders, and are medically and immunologically acceptable gelatin. Alkylated gelatins, cf. for example. DE 19721238 for alkylene succinated gelatin, can be used to alter the interaction of the polypeptide with the skin and hence influence the water fastness of the UV-absorbing polymer. Thus to improve the interaction of the UV-absorbing compounds of the present invention with the skin, alkyl groups, such as for example alkylene succinyl groups, may additionally be coupled to the carrier in the UV-absorbing compound. Alternatives for alkylene succinyl groups are readily known to the skilled person or can easily be identified in terms of having an improved water fastness. Thus in an embodiment the invention relates to UV-absorbing polymers as defined above wherein the polymer P further comprises alkyl groups, preferably alkylene succinyl groups, to improve water fastness, wherein the alkyl groups and the alkylene groups have 4 to 25 carbon atoms. Modified gelatins in which the amount of free amine-groups has been increased can be used to increase the load of the amino butadienes according to formula (I) on the gelatin. EP A 487.686 discloses a method to convert carboxy groups into amines. In addition, spacers can be used to increase the amount of free reactive groups in a polypeptide. A spacer is a molecule which can be covalently linked to reactive groups of the polypeptide, like carboxy groups or amine groups, said spacer molecule comprising at least two reactive groups like amine groups or carboxy groups. Examples of suitable spacers are amino acids, e.g. lysine, glutamic acid and aspartic acid.
Coupling of the aminobutadiene to the polymer P
According to the invention, the aminobutadiene according to formula (I) is coupled directly to polymer P by mixing the aminobutadiene with the polymer P. The aminobutadiene is coupled to polymer P in an amount of at least about 7.6 mmol per 100 gram polymer P, preferably in an amount of at least about 10 mmol per 100 gram polymer P, more preferably at least about 20 mmol per 100 gram polymer P, even more preferably at least about 40 mmol per 100 gram polymer P and most preferably at least about 100 mmol per 100 gram polymer P. The amount of aminobutadienes used can also be expressed as a percentage of amine groups in polymer P which is bonded to an amino butadiene. Most preferably, 100% of the amine groups is coupled to an aminobutadiene. Generally, good results can already be obtained when more than 50% of the amine groups is linked to an aminobutadiene. The coupled amounts necessary to reach the preferred UV-absorption may obviously vary between different aminobutadiene structures since said aminobutadiene structures can be expected to have varying extinction coefficients.
High molecular weight of polypeptides, i.e. over 100 kD, are less preferred. Such large molecules may give problems as to insufficient penetration in cosmetic applications. The molecular weight of conventional natural or modified polypeptides, in particular gelatins, can be regulated by for example hydrolysis or by enzymatic breakdown of the polypeptide. The desired average molecular weight can be regulated satisfactorily, although the molecular weight distribution can be problematic. After breakdown of the polypeptide too smaller fragments (i.e. lower than about 3 kD), larger fragments can be removed by known techniques such as ultra filtration, dialysis, noodle washing and the like. Recombinant produced gelatins have the additional advantage that the molecular weight and the molecular weight distribution can be regulated precisely. Another method to regulate skin penetration is to adjust the hydrophobicity of the polypeptide by chemical modification of the polypeptide, covalently linking hydrophilic or hydrophobic groups to the polypeptide. The direct coupling process can be performed in various solvents. Preferred solvents are those in which gelatin and the aminobutadiene dissolve completely. Preferred solvents are those selected from the group consisting of dimethyl formamide
(DMF), dimethyl acetamide (DMAC), dimethylsulfoxide (DMSO), N-methyl pyrollidone (NMP), 1,2-ethanediol, tetrahydrofuran (THF), water and mixtures thereof. The coupling reaction can be carried out in any suitable reaction vessel at a temperature between -200C and 1500C, depending on the solvent(s) used. At higher temperatures the aminobutadiene may be instable. Preferably, the temperature is between 00C and 1000C. More preferred are temperatures between 100C and 800C. Other suitable temperatures are from 200C and 300C. At higher gelatin concentrations temperatures of between than 35°C and 500C may be preferred.
According to the present invention, a base or a basic compound is present during direct coupling. Use of such basic compounds may increase the coupling yield with at least 30% - 50%. Suitable organic basic compounds comprise tertiary amines such as for example triethylamine and diisopropylethylamine. Suitable inorganic basic compounds are for example carbonate salts and hydroxides.
The preferred amount of basic compound added is between 0.2 and 3 mol equivalents of the aminobutadiene. Preferably, between 0.5 and 2 mol equivalents are added, and most preferably from 0.7 to 1.0 mol equivalents. The amount of organic base necessary to reach a specific yield can be up 1.5 times higher compared to an inorganic base.
Consequently, the method according to the present invention has an advantage over the method disclosed in WO 2004/075871 since no activation steps or other pre- coupling steps are necessary to couple the polymer P to the aminobutadiene.
The UV-absorbing polymer and cosmetic compositions
The a UV-absorbing polymer according to the invention that is prepared by coupling an aminobutadiene of formula (I) to the polymer P according to formula (II) has a UV-absorption of at least 5.6 a.u./g.L at 375 nm. This minimum UV-absorption is required to avoid any detrimental effects on the stability and viscosity of the sunscreen formulation. A lower absorption than 5.6 a.u./g.L at 375 nm requires a higher amount of the UV-absorbing polymer in the sunscreen composition giving rise to formulation problems such as stability and viscosity problems. Preferably, the UV-absorbing polymer of this invention has a UV-absorption of at least 20 a.u./g.L, more preferably
of al least 25 a.u./g.L, even more preferably of at least 30 a.u./g.L and most preferably of at least 40 a.u./g.L.
The present invention is also directed to the use of the UV-absorbing polymers according to the invention to protect the human skin or hair from the detrimental effects of exposure to sunlight. The present invention is especially directed to sunscreen compositions comprising stable UV-absorbing polymers that cannot penetrate through the skin into the bloodstream. Preventing the UV absorbing compound from entering the bloodstream reduces the risk of immune reactions or other detrimental effects.
In a preferred embodiment the UV-absorbing polymer absorbs less than 10% of its total absorption above 400 nm. This means that the UV-absorbing polymer is substantially transparent for visible light. In a preferred embodiment, the UV-absorbing polymer has 75% or more of its total absorption in the UV-A region between 315 and 400 nm. Thus the invention relates to a UV-absorbing polymer as defined above wherein less than 10% of the total absorption between 250 and 600 nm of said UV- absorbing compound is above 400 nm. Also the invention relates to a UV-absorbing polymer as defined above wherein at least 75% of the total absorption between 250 and 600 nm of said UV-absorbing compound is between 315 and 400 nm.
The depth of penetration in the skin can be advantageously regulated by controlling the molecular weight of the UV-absorbing polymer which prevents it from entering the bloodstream. In the prior art, no methods are known to control the skin penetration, but allow skin penetration freely. In the present invention even shallow penetration of the skin is prevented.
The UV-absorbing compound can be advantageously used for the preparation of cosmetic or sunscreen compositions to protect the skin or hair from UV radiation. Various forms of cosmetic compositions for skin protection comprising UV- absorbing compounds are available in the market as lotions, emulsions, creams, milks, gels and the like. These may contain oil and/or alcohol. Also aerosols or sticks are known to be used. All such forms of cosmetic compositions may function as a medium to apply the polypeptide. One skilled in the art will be able to select suitable cosmetically and dermatologically carriers that can be used in the sunscreen composition of the invention, in particular in combination which polypeptide to which aminobutadiene is linked.
The sunscreen comprising can contain a second, conventional, UV-absorbing compound. This can be a UV-A, UV-B or broadband UV absorbing compound as described in for example EP A 1.055.412. Other additives as applied in the art may also be used. The cosmetic compositions of the present invention can contain in addition to the
UV-absorbing compound various adjuvants conventionally present in cosmetic compositions of this type for example hydrating agents, emollients or thickening agents, surfactants, preservatives, perfumes, dyes, etcetera.
The invention further relates to a sunscreen composition comprising less than 18 wt%, preferably less than 13 wt%, more preferably less than 10 wt% of the UV- polymer compound according to the present invention.
EXAMPLES
Example 1. Direct coupling to gelatin of compound (Ve) [compound (V) in which R6 is ethyl and R7 is methyl]
12.5 g of gelatin (hydrolysed Pigskin gelatin, average MW = 2 kD) was dissolved in 47 g of N-methyl pyrollidone (NMP) at 600C in 2 hours while stirring. Then, 5 g of compound (Ve) and 1.7 ml of a 25% aqueous solution of sodium carbonate was added. The reaction mixture was stirred for another 2 hours at 500C. The modified gelatin was precipitated by slowly adding the reaction mixture to 165 ml ethyl acetate. The solid was filtered off and washed two times, by stirring for 20 minutes in 150 ml ethyl acetate. Following the above procedure, 13.0 g UV-gelatin was obtained with a specific absorption E (370 nm, DMSO, 1%/lcm) = 350 a.u.. The specific absorption is determined by UV-spectroscopy at 370 nm and is defined as the absorption of a 1% (10 g/L) solution at a path length of 1 cm.
Example 2. Direct coupling to gelatin of compound (Vi) [compound (V) in which R6 is isopropyl and R7 is methyl]
12.5 g of the gelatin (hydrolysed Pigskin gelatin, average MW = 2 kD) was dissolved in 47 g of N-methyl pyrollidone (NMP) at 600C in 2 hours while stirring. Then, 5.17 g
of compound (Vi) and 1.7 ml of a 25% aqueous solution of sodium carbonate was added. The reaction mixture was stirred for another 2 hours at 500C. The modified gelatin was precipitated by slowly adding the reaction mixture to 165 ml ethyl acetate. The solid was filtered off and washed two times, by stirring for 20 minutes in 150 ml ethyl acetate. Following the above procedure 14.5 g UV-gelatin is obtained with a specific absorption E (370 nm, DMSO, 1%/1 cm) = 327 a.u..
Example 3. Direct coupling to hydro lysed wheat protein of compound (Ve)
12.5 g of the wheat protein (average molecular weight 2 kD, Plantasol W) was dissolved in 47 g of N-methyl pyrollidone (NMP) at 600C in 2 hours while stirring. Then, 5 g of compound (Ve) and 1.7 ml of a 25% aqueous solution of sodium carbonate was added. The reaction mixture was stirred for another 2 hours at 500C. The modified wheat protein was precipitated by slowly adding the reaction mixture to 165 ml ethyl acetate. The solid was filtered off and washed two times, by stirring for 20 minutes in 150 ml ethyl acetate. Following the above procedure 12.O g UV-protein is obtained with a specific absorption E (370 nm, DMSO, 1%/1 cm) = 160 a.u..
Claims
1. Process for the preparation of UV-absorbing polymers wherein an amino butadiene derivative according to formula (I) is reacted in the presence of a base with a polymer P having at least one amine group -NHR* according to formula (II):
(I) (H)
wherein:
Ri and R2, which may be the same or different, each represents a hydrogen atom, an optionally substituted linear or branched alkyl group having 1 - 20 carbon atoms, an optionally substituted aryl group having 6 - 20 carbon atoms, or an optionally substituted alkaryl or arylalkyl group having 7 - 20 carbon atoms, provided that Ri and R2 do not simultaneously represent hydrogen atoms;
R3 represents -COOH, -COOR5, -COR5, CN or SO2R5 and R4 represents -COOH, -COOR5, -COR5, CN or SO2R5, wherein R5 and R6, which may be the same or different, each represents an optionally substituted linear or branched alkyl group having 1 - 25 carbon atoms, an alkyl group having 1 - 25 carbon atoms and one or more carbon-carbon double bonds and/or triple bonds, wherein the alkyl group optionally comprises one or more hetero-atoms selected from the group consisting of O, N, Si and S, an optionally substituted aryl group having 6 to 20 atoms, or an optionally substituted alkaryl or arylalkyl group having 7 - 20 carbon atoms; optionally R5 and R6 can combine and form a ring structure, said ring structure preferably being a five to seven membered ring structure, which is optionally substituted and which optionally comprises N, O and/or carbonyl groups;
R* is hydrogen or a linear or branched Ci - Ce alkyl group; and the polymer P is a polypeptide, provided that the polymer P is not a synthetic amine rich polymer.
2. Process according to Claim 1, wherein at least one of Ri and R2 is a group of formula R7-C(O)-, wherein R7 is a hydrogen atom or an optionally substituted alkyl group having 1 to 20 carbon atoms.
3. Process according to Claim 1 or Claim 2, wherein one of Ri and R2 is a group of the formula R7-C(O)- whereas the other is an optionally substituted phenyl group of 6 to 20 carbon atoms.
4. Process according to any one of Claims 1 - 3, wherein the UV-absorbing polymer has a UV-absorption of at least 5.6 a.u./g.L at 375 nm.
5. Process according to any of Claims 1 - 4, wherein the amino butadiene is represented by the following general formula (III)
(III)
wherein R1, R2, R4 and R5 are as defined as in claim 1.
6. Process according to any one of Claims 1 - 5, wherein the amino butadiene is represented by the following general formula (IV):
(IV)
wherein R1, R2 and R5 are as defined in Claim 1 and wherein R6 is a linear or branched alkyl group having 10 - 20 carbon atoms.
7. Process according to any one of Claims 1 - 6, wherein the aminobutadiene is represented by the following formula (V):
wherein R6 has the same meaning as in Claim 1 and wherein R7 is a hydrogen atom or an optionally substituted alkyl group having 1 to 20 carbon atoms.
8. Process according to any one of the preceding claims, wherein the polypeptide is a polymer having at least 15 amino acids up to 2000 amino acids linked by peptide bonds.
9. Process according to Claim 8, wherein the polypeptide is a collagen-like or gelatin-like polypeptide comprising at least one stretch of five or more consecutive repeats of Gly-Xaa-Yaa triplets.
10. Process according to Claim 9, wherein in the collagen-like or gelatin-like polypeptide at least 20% of the amino acids are present in the form of consecutive Gly-Xaa-Yaa triplets.
11. Process according to any one of Claims 1 - 7, wherein the polypeptide is selected from the group consisting of casein, sericin, soluble collagen, gelatin and derivatives thereof.
12. Process according to Claim 11, wherein the polypeptide is a gelatin or a derivative thereof comprising 30 to 300 amino acids.
13. UV-absorbing polymer obtainable by the process of any one of Claims 1 - 12.
14. Use of the UV-absorbing polymer according to Claim 13 in cosmetic compositions.
15. Use according to Claim 14, wherein the cosmetic composition is a sunscreen formulation.
16. Cosmetic composition comprising the UV-absorbing polymer according to Claim 13.
17. Cosmetic composition according to Claim 16, wherein the cosmetic composition is a sunscreen formulation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06100271 | 2006-01-12 | ||
EP06100271.3 | 2006-01-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007081209A1 true WO2007081209A1 (en) | 2007-07-19 |
Family
ID=36572387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL2007/050010 WO2007081209A1 (en) | 2006-01-12 | 2007-01-10 | Uv-absorbing polymers consisting of gelatin and aminobutadiene |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007081209A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9248092B2 (en) | 2012-06-28 | 2016-02-02 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing an ultraviolet radiation-absorbing polymer |
US9255180B2 (en) | 2012-06-28 | 2016-02-09 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polyethers |
US9469725B2 (en) | 2012-06-28 | 2016-10-18 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polymers |
US9592190B2 (en) | 2012-06-28 | 2017-03-14 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing an ultraviolet radiation-absorbing polyester |
CN110596283A (en) * | 2019-07-19 | 2019-12-20 | 深圳市计量质量检测研究院(国家高新技术计量站、国家数字电子产品质量监督检验中心) | Liquid chromatography-mass spectrometry method for identifying species attributes of leather products such as pigs, cattle and sheep |
US10596087B2 (en) | 2016-10-05 | 2020-03-24 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polymer composition |
US10874603B2 (en) | 2014-05-12 | 2020-12-29 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing a UV-absorbing polyglycerol and a non-UV-absorbing polyglycerol |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4824902A (en) * | 1987-08-31 | 1989-04-25 | Eastman Kodak Company | Latex composition comprising polycarbonate having tertiary amine acid addition moiety |
EP0412570A2 (en) * | 1989-08-11 | 1991-02-13 | Fuji Photo Film Co., Ltd. | Light- and heat-sensitive recording material |
DE19721238A1 (en) * | 1997-05-21 | 1998-11-26 | Stoess & Co Gelatine | Alkyl-succinate-modified gelatine for ink-receiving layer of ink-jet printer paper |
WO2004075871A1 (en) * | 2003-02-26 | 2004-09-10 | Fuji Photo Film B.V. | Cosmetic uv-screen compositions and aminobutadiene-based uv-absorbing complexes therefor |
WO2006009451A1 (en) * | 2004-07-23 | 2006-01-26 | Fuji Photo Film B.V. | Dendrimer-aminobutadiene-based uv-screens |
WO2006016806A1 (en) * | 2004-08-11 | 2006-02-16 | Fujifilm Manufacturing Europe B.V. | Aminobutadiene-based uv screens |
-
2007
- 2007-01-10 WO PCT/NL2007/050010 patent/WO2007081209A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4824902A (en) * | 1987-08-31 | 1989-04-25 | Eastman Kodak Company | Latex composition comprising polycarbonate having tertiary amine acid addition moiety |
EP0412570A2 (en) * | 1989-08-11 | 1991-02-13 | Fuji Photo Film Co., Ltd. | Light- and heat-sensitive recording material |
DE19721238A1 (en) * | 1997-05-21 | 1998-11-26 | Stoess & Co Gelatine | Alkyl-succinate-modified gelatine for ink-receiving layer of ink-jet printer paper |
WO2004075871A1 (en) * | 2003-02-26 | 2004-09-10 | Fuji Photo Film B.V. | Cosmetic uv-screen compositions and aminobutadiene-based uv-absorbing complexes therefor |
WO2006009451A1 (en) * | 2004-07-23 | 2006-01-26 | Fuji Photo Film B.V. | Dendrimer-aminobutadiene-based uv-screens |
WO2006016806A1 (en) * | 2004-08-11 | 2006-02-16 | Fujifilm Manufacturing Europe B.V. | Aminobutadiene-based uv screens |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9737470B2 (en) | 2012-06-28 | 2017-08-22 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing an ultraviolet radiation-absorbing polymer |
US9255180B2 (en) | 2012-06-28 | 2016-02-09 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polyethers |
US9254254B2 (en) | 2012-06-28 | 2016-02-09 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing an ultraviolet radiation-absorbing polymer |
US9469725B2 (en) | 2012-06-28 | 2016-10-18 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polymers |
US9592190B2 (en) | 2012-06-28 | 2017-03-14 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing an ultraviolet radiation-absorbing polyester |
US9737471B2 (en) | 2012-06-28 | 2017-08-22 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing an ultraviolet radiation-absorbing polymer |
US9248092B2 (en) | 2012-06-28 | 2016-02-02 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing an ultraviolet radiation-absorbing polymer |
US9758618B2 (en) | 2012-06-28 | 2017-09-12 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polyethers |
US10278910B2 (en) | 2012-06-28 | 2019-05-07 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing an ultraviolet radiation-absorbing polymer |
US10874603B2 (en) | 2014-05-12 | 2020-12-29 | Johnson & Johnson Consumer Inc. | Sunscreen compositions containing a UV-absorbing polyglycerol and a non-UV-absorbing polyglycerol |
US10596087B2 (en) | 2016-10-05 | 2020-03-24 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polymer composition |
US10874597B2 (en) | 2016-10-05 | 2020-12-29 | Johnson & Johnson Consumer Inc. | Ultraviolet radiation absorbing polymer composition |
CN110596283A (en) * | 2019-07-19 | 2019-12-20 | 深圳市计量质量检测研究院(国家高新技术计量站、国家数字电子产品质量监督检验中心) | Liquid chromatography-mass spectrometry method for identifying species attributes of leather products such as pigs, cattle and sheep |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060204457A1 (en) | Cosmetic uv-screen compositions and aminobutadiene-based uv-absorbing complexes therefor | |
WO2007081209A1 (en) | Uv-absorbing polymers consisting of gelatin and aminobutadiene | |
ES2246084T5 (en) | DERIVATIVES OF POLYAMINO-ACIDS AND ITS USE IN COMPOSITIONS OF TREATMENT OF KERATIN FIBERS. | |
US7060260B2 (en) | Water-soluble silk proteins in compositions for skin care, hair care or hair coloring | |
US7691806B2 (en) | Repeat sequence protein polymer active agent congjugates, methods and uses | |
JP3462128B2 (en) | Polypeptide-polysiloxane copolymers, their preparation and their use as surfactants | |
EP0832642B1 (en) | Derivatives of Benzoxazole useful as uv filters | |
CA2282674A1 (en) | Hair treatment method | |
JPH07509012A (en) | synthetic melanin | |
FR2586692A1 (en) | NOVEL POLYAMINOAMIDES FILTERING ULTRAVIOLET RADIATION, PROCESS FOR PREPARING SAME AND USE THEREOF FOR PROTECTING SKIN AND HAIR | |
AU2003221870B2 (en) | Heterogeneous protein networks crosslinked with silicone-containing links, and methods for producing them | |
US7285285B2 (en) | Photoactivatable diazirine-active agent compounds, compositions comprising them and uses thereof | |
EP1784455A1 (en) | Dendrimer-aminobutadiene-based uv-screens | |
WO2009051460A2 (en) | Peptide coupled ascorbic acid derivatives | |
WO2015046968A1 (en) | Organic/inorganic hybrid tio2 complex, cosmetic composition containing same, and method for manufacturing same | |
BR102014031665A2 (en) | sunscreen compositions containing a polymer capable of absorbing ultraviolet radiation | |
KR20180017459A (en) | Cosmetics compositions for antioxidant | |
EP1401504B1 (en) | Uv-screening peptide-flavonoid conjugates | |
JP2013006810A (en) | Cosmetic for eyelash | |
CN118475335A (en) | Sunscreen compositions comprising imine analogues of ketone-containing sunscreens | |
KR102502513B1 (en) | Composition for dyeing | |
FR2839446A1 (en) | PHOTO-ACTIVATED DIAZIRIN-ACTIVE COMPOUNDS, COMPOSITIONS CONTAINING SAME AND USES THEREOF | |
WO2000014176A1 (en) | Piperidine antioxidants and compositions therewith for preventing the fading of artificial hair dye | |
JP2020029433A (en) | Peptide modified with cinnamic acid family | |
JP6132299B2 (en) | Composition comprising collagen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07709158 Country of ref document: EP Kind code of ref document: A1 |